[Incidence of severe side effects during nalidixic acid therapy in young children].
D001049:Apnea / Q000139:chemically induced; D001927:Brain Diseases / Q000139:chemically induced; D002648:Child; D004417:Dyspnea / Q000139:chemically induced; D004487:Edema; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008578:Meninges / Q000187:drug effects; D009268:Nalidixic Acid / Q000009:adverse effects*; D011704:Pyelonephritis / Q000188:drug therapy*; D012640:Seizures / Q000139:chemically induced; D014581:Urticaria / Q000139:chemically induced
D009268:Nalidixic Acid
Uber das Vorkommen schwerer Nebenwirkungen bei jungen Kindern unter der Behandlung mit Nalidixinsäure.